Lupus: Open Access
Open Access

Abstract

Overview, Daignosis and Treatment of Lupus Anticoagulant Syndrome

Ryes Andrew*

Lupus anticoagulants are a diverse class of immunoglobulins that particularly target epitopes that are part of the negative-charged phospholipid binding protein of the cell membrane, prothrombin, and beta2-GPI, inhibiting phospholipid-dependent coagulation invitro. Antiphospholipid syndrome is an uncommon autoimmune condition characterised by the formation of blood clots in numerous regions of the body. Because it is more common in patients with lupus, it is also known as lupus anticoagulant syndrome.

Published Date: 2023-07-04; Received Date: 2023-06-01